| 摘要 |
Methods of treating subjects having a cancer-related, immune-related, or viral-related disease, disorder or condition via administration of an IL-10 agent, including pegylated IL-10, and an IL-7 agent are provided, as are methods of identifying subjects that may be responsive to treatment with an IL-10 agent. |
